A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Pantoprazole And Pantoprazole Monotherapy In Treatment Of Patients With Nonsteroidal Anti-Inflammatory Drugs (NSAID)-Induced Gastropathy

Condition:   NSAID-induced GastropathyInterventions:   Drug: bismuth tripotassium dicitrate;   Drug: pantoprazoleSponsor:   Astellas Pharma Europe B.V.Not yet recruiting - verified May 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials